 |
|
Status and trends in epidemiologic characteristics of diabetic end-stage renal disease: an analysis of the 2021 Korean Renal Data System
Kyeong Min Kim, Seon A Jeong, Tae Hyun Ban, Yu Ah Hong, Seun Deuk Hwang, Sun Ryoung Choi, Hajeong Lee, Ji Hyun Kim, Su Hyun Kim, Tae Hee Kim, Ho-Seok Koo, Chang-Yun Yoon, Kiwon Kim, Seon Ho Ahn, Yong Kyun Kim, Hye Eun Yoon
Kidney Res Clin Pract. 2024;43(1):20-32. Published online 2024 Jan 25 DOI: https://doi.org/10.23876/j.krcp.23.130
|
|
Citations to this article as recorded by
 Chronic Kidney Disease and SGLT2 Inhibitors
Eun Sil Koh, Sungjin Chung
The Journal of Korean Diabetes.2024; 25(1): 16. CrossRef Clinical Impact of the Use of Warfarin in Patients with Atrial Fibrillation Undergoing Maintenance Hemodialysis
Seok Hui Kang, Gui Ok Kim, Bo Yeon Kim, Eun Jung Son, Jun Young Do
Journal of Clinical Medicine.2024; 13(8): 2404. CrossRef Screening of potential drugs for the treatment of diabetic kidney disease using single-cell transcriptome sequencing and connectivity map data
Yi Li, Shaohui Gao, Zhaochen Guo, Zige Chen, Yihan Wei, Yutong Li, Yani Ba, Zhihong Liu, Hao Bao
Biochemical and Biophysical Research Communications.2024; 725: 150263. CrossRef Krüppel-like factor 15 is a key suppressor of podocyte fibrosis under rotational force-driven pressure
Mi-Yeon Yu, Ji Eun Kim, Saram Lee, Jin Woo Choi, Yong Chul Kim, Seung Seok Han, Hajeong Lee, Ran Hui Cha, Jung Pyo Lee, Jae Wook Lee, Dong Ki Kim, Yon Su Kim, Seung Hee Yang
Experimental Cell Research.2020; 386(1): 111706. CrossRef
|